Erick DeVinney serves as the Vice President of Peripheral Nerve Science at Axogen Inc., a leading company in the field of peripheral nerve repair. With a robust background in biomedical sciences and a strong commitment to advancing nerve repair technologies, DeVinney has become an integral part of Axogen's mission to improve patient outcomes. He holds a Ph.D. in Biomedical Sciences from the University of California, San Diego, and has over a decade of experience in research and development within the medical device industry. In his role at Axogen, DeVinney is responsible for overseeing the scientific advancement and clinical application of the company's peripheral nerve repair products. His leadership has been pivotal in driving the development of innovative solutions that address unmet needs in nerve repair and regeneration. Under his guidance, Axogen has successfully expanded its portfolio of products, which are now used by surgeons worldwide to treat traumatic nerve injuries and improve patients' quality of life. DeVinney's work has been recognized with several industry awards, and he is frequently invited to speak at major medical conferences, sharing insights on the latest advancements in peripheral nerve repair. Before joining Axogen, DeVinney held various research positions at prominent institutions, where he contributed to numerous peer-reviewed publications and patents. His expertise in neurobiology and tissue engineering has not only strengthened Axogen's scientific foundation but also fostered collaborations with leading academic and clinical partners. As a key member of the executive team, DeVinney continues to play a crucial role in shaping the future of peripheral nerve repair, ensuring that Axogen remains at the forefront of this critical field.